Finance

Lists
Why is NVCR up 4,12%?
Dive Deeper
NVCR:NASDAQ
Novocure Ltd
USD 14,41
+4,12%
(+0,57) 1D
USD 14,41
0,00% (0,00)
After hours
Closed: 15 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCR...
Open
USD 13,85
High
USD 14,46
Low
USD 13,84
Mkt. cap
1,68 mjd
Avg. vol.
1,29 m
Volume
1,67 m
52-wk high
USD 21,36
52-wk low
USD 9,82
EPS
-USD 1,31
Beta
0,99
Shares outstanding
116,45 m
No. of employees
2 k
Open
USD 13,85
High
USD 14,46
Low
USD 13,84
Mkt. cap
1,68 mjd
Avg. vol.
1,29 m
Volume
1,67 m
52-wk high
USD 21,36
52-wk low
USD 9,82
EPS
-USD 1,31
Beta
0,99
Shares outstanding
116,45 m
No. of employees
2 k
News stories
From web sources and news partners
About Novocure Ltd
CEOAsaf Danziger
Employees1,6 k
Founded2000
Headquarters-
SectorMedical device
Websitenovocure.com
Analyst ratings
Based on 3 analysts giving stock ratings to NVCR in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NVCR in the last 3 months.
Highest
Current USD 14,41
USD 52,00 (+260,86%)
Average
USD 33,67 (+133,66%)
Lowest
USD 20,00 (+38,79%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Hold
Maintained
USD 20,00
+38,8%
07/24/2026
Jason Bednar
Piper Sandler
Buy
Maintained
USD 29,00
+101,2%
07/24/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
USD 52,00
+260,9%
07/24/2026
Jessica Fye
J.P. Morgan
Hold
Maintained
USD 17,00
+18%
07/13/2026
Unknown Analyst
Wedbush
Hold
Maintained
USD 18,00
+24,9%
06/30/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
USD 17,00
+18%
05/04/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 20,00
+38,8%
05/01/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Maintained
USD 27,00
+87,4%
02/27/2026
Next call oor 14 dae
Do. 29 Okt., 14:00
Fiscal period
Q3 2026
- / -USD 0,23
Revenue / Est. (USD)
- / 182,23 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
167,20 m
174,35 m
174,06 m
183,58 m
Cost of goods sold
44,73 m
40,45 m
38,93 m
41,11 m
Cost of revenue
44,73 m
40,45 m
38,93 m
41,11 m
Research and development expenses
54,03 m
60,90 m
58,34 m
51,45 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,47 m
110,18 m
144,21 m
101,59 m
Operating expense
158,50 m
171,09 m
202,55 m
153,04 m
Total operating expenses
203,22 m
211,53 m
241,48 m
194,15 m
Operating income
-36,02 m
-37,18 m
-67,42 m
-10,56 m
Other non operating income
-
-858,00 k
-
-
EBT including unusual items
-30,02 m
-40,95 m
-69,26 m
-12,45 m
EBT excluding unusual items
-30,02 m
-64,64 m
-69,26 m
-12,45 m
Income tax expense
7,25 m
-16,46 m
1,88 m
3,21 m
Effective tax rate
-24,14%
40,18%
-2,71%
-25,75%
Other operating expenses
-
-
-
-
Net income
-37,27 m
-24,50 m
-71,14 m
-15,66 m
Net profit margin
-22,29%
-14,05%
-40,87%
-8,53%
Earnings per share
-0,33
-0,22
-0,62
-0,13
Interest and investment income
9,80 m
-
3,53 m
3,57 m
Interest expense
-3,80 m
-22,27 m
-5,37 m
-5,46 m
Net interest expenses
6,00 m
-22,27 m
-1,84 m
-1,89 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-32,36 m
-34,48 m
-63,30 m
-6,26 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme